La vendita allo scoperto per Tidal Trust II YieldMax BRK.B Option Income Strategy ETF dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Tidal Trust II YieldMax BRK.B Option Income Strategy ETF. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Tidal Trust II YieldMax BRK.B Option Income Strategy ETF (ARCA:BRKC), Report sulle vendite allo scoperto

The Fund is an actively managed exchange-traded fund (ETF) that seeks current income while providing indirect exposure to the share price (i.e., the price returns) of the common stock of Berkshire Hathaway Inc. (BRK.B or the Underlying Security), subject to a limit on potential investment gains. The Fund will seek to employ its investment strategy as it relates to BRK.B regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. As further described below, the Fund uses either a synthetic covered or a synthetic covered call spread strategy call strategy to provide income and indirect exposure to the share price returns of BRK.B, subject to a limit on potential investment gains as a result of the nature of the options strategy it employs. That is, the Fund not only seeks to generate income from its options investments but also aims to derive gains when the value of BRK.B increases.

YieldMax BRK.B Option Income Strategy ETF

Tidal Trust II YieldMax BRK.B Option Income Strategy ETF

BARKSDALE RES CORP by Barksdale Resources Corp.

Barksdale Resources Corp

Cogent Biosciences, Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. 
With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration approval by the end of 2025. 
The results not only validate Cogent's targeted approach but also position bezuclastinib as a potential first-in-class therapy for a condition with limited treatment options.
<a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">Systemic mastocytosis (NonAdvSM)</a> is a rare disease characterized by the abnormal accumulation of mast cells in various tissues, including the bone marrow, skin, and other organs.
The latest study demonstrated meaningful and highly statistically significant improvements across the primary and all key secondary endpoints, including patient-reported symptoms and <a href="https://www.benzinga.com/pressreleases/25/07/g46270932/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-a" target="_blank" rel="noreferrer noopener">objective measures of mast cell burden</a>.
Also Read: <a href="https://www.benzinga.com/24/11/41987123/blood-cancer-focused-blueprint-medicines-could-be-attractive-target-for-partnerships-analyst-initiates-with-around-30-upside" target="_blank" rel="noreferrer noopener">Blood Cancer-Focused Blueprint Medicines Could Be &#8216;Attractive Target For Partnerships&#8217;: Analyst</a>
Based on these data, Cogent is on track to submit its first new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for bezuclastinib in NonAdvSM by the end of 2025.
In addition, Cogent plans to present detailed results from the SUMMIT trial at an upcoming medical meeting later this year.
The SUMMIT trial achieved its primary endpoint with a statistically significant difference in the mean change in total symptom score (TSS) at 24 weeks.
The bezuclastinib arm had a mean reduction of 24.3 points in TSS at 24 weeks, versus the placebo arm, which had a mean reduction of 15.4 points, resulting in a placebo-adjusted TSS improvement of 8.91 points.
In addition, the SUMMIT trial demonstrated statistically significant benefit across all key secondary endpoints, including reduction of serum tryptase on which 87.4% of bezuclastinib-treated patients had ≥50% reduction, compared to no patients in the control arm (87.4% vs. 0%).
Complete analysis of the full SUMMIT Part 2 data is ongoing, and Cogent plans to present detailed results at a major medical conference later this year.
Cogent remains on track to provide topline results from both PEAK, a Phase 3 trial of bezuclastinib in combination with sunitinib in patients with gastrointestinal stromal tumors, and APEX, a registration-directed trial of bezuclastinib in advanced systemic mastocytosis patients, during the second half of 2025.
The company has a cash balance of $237 million and access to an additional $350 million via a recently announced debt facility with SLR Capital Partners.
Price Action: At the last check on Monday, COGT stock was up 15.7% at $8.77 during the premarket session.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46269806/pony-ai-to-deploy-robotaxis-in-dubai-trials-begin-late-2025" target="_blank" rel="noreferrer noopener">Pony.ai To Deploy Robotaxis In Dubai, Trials Begin Late 2025</a></li>
</ul>
Image: Shutterstock

Biotech

News

Health Care

Movers

Trading Ideas

General

COGT

Why Is Cogent Biosciences Stock Trading Higher On Monday?

Tesla is swimming in contradiction. On the one hand, it&#8217;s a $1 trillion behemoth, rivaling the economy of an entire small nation. On the other hand, investors are jittery: shares are down about 17 % year-to-date, and profits and deliveries have just <a href="https://www.benzinga.com/topic/tesla">hit multi-quarter lows.</a>
The culprit? CEO Elon Musk's escalating political ambitions—and a glaring lack of an alternative CEO.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46268694/elon-musks-america-party-plans-conflict-with-his-full-time-responsibilities-as-tesla-ceo-says-former-doge-advisor">Elon Musk&#8217;s America Party Plans &#8216;Conflict&#8217; With His Full-Time Responsibilities As Tesla CEO, Says Former DOGE Advisor</a>
<h2 class="wp-block-heading">Musk's America Party Rocks Tesla's World</h2>
Tesla's stock dropped nearly 7 % in pre-market trading on Monday after Musk unveiled his "America Party," reviving investor fears that he's losing focus on the automaker's core mission.
Concerns extend beyond political squabbles: analysts like Neil Wilson from Saxo Markets warn that Musk's political distraction could jeopardize subsidies and contracts, potentially pushing the stock from a &#8220;vision premium&#8221; to a governance discount, according to Reuters.
<h2 class="wp-block-heading">No Plan B: Tesla's Leadership Vacuum</h2>
It's not just that Musk might start spending more time with lobbyists than on factory floors. Institutional investors are now demanding that he commit full-time to Tesla<a href="https://www.washingtonpost.com/technology/2025/05/28/musk-tesla-board-succession-plan/">,</a> with a minimum of 40 <a href="https://www.washingtonpost.com/technology/2025/05/28/musk-tesla-board-succession-plan/">hours</a> per week, amid falling profits and stagnating sales, according to The Washington Post.
Tesla has no clear succession plan. There&#8217;s no Tim Cook waiting in the wings—just Tom Zhu's low-profile stint in China. For a company trading at ~180x P/E, that's not just risky &#8211; it's existential.
<h2 class="wp-block-heading">Valuation On Thin Ice</h2>
Tesla's valuation is sky-high:
<ul class="wp-block-list">
<li>P/E (TTM): 180x</li>
<li>Forward P/E: 164x</li>
<li>EV/EBITDA: ~73x</li>
<li>PS ratio: ~11.6x</li>
</ul>
Data Source: <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0707">Benzinga Pro</a>
At these multiples, markets aren't just pricing in Tesla's EV future &#8211; they're betting Musk stays at the wheel every day. That's a tall order &#8211; even for the world's richest man.
<h2 class="wp-block-heading">The &#8216;Musk Premium&#8217; On Thin Ice</h2>
Tesla's growth story depends not just on innovation &#8211; but on uninterrupted leadership. As Musk flips the script toward politics, the "Musk premium" powering Tesla stock is buckling.
Without a concrete succession plan or a disciplined CEO, that premium could quickly evaporate. And Tesla's valuation may be riding on ice that's about to crack.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46261711/forget-robotaxis-ford-just-drove-straight-into-teslas-valuation-problem">Forget Robotaxis &#8211; Ford Just Drove Straight Into Tesla&#8217;s Valuation Problem</a></li>
</ul>
Photo: Jonathan Weiss on Shutterstock.com

Long Ideas

Tech

TSLA

No Plan B - Tesla's Musk Premium Is On Thin Ice

Offerings

AMBR

Amber International Files For Mixed Shelf Offering Of Up To $500M

Citigroup analyst Matthew Herrmann initiates coverage on Ategrity Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIC#NYSE">ASIC</a>) with a Neutral rating and announces Price Target of $26.

Price Target

Initiation

Analyst Ratings

ASIC

Citigroup Initiates Coverage On Ategrity Specialty with Neutral Rating, Announces Price Target of $26

Agreement provides for the launch of the remaining nine replacement satellites under construction by Macdonald, Dettwiler and Associates Corporation ("MDA")
Globalstar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#NASDAQ">GSAT</a>), a next-generation telecommunications infrastructure and technology provider, today announces that the Company has signed an agreement with SpaceX for a Falcon 9 launch for the next set of satellites, pursuant to the 2022 satellite procurement agreement with MDA. As previously disclosed, these satellites will provide continuous satellite services in combination with the existing second-generation satellites in operation today. Globalstar expects the launch will take place next year following the initial launch this year. These satellites have been authorized by the Federal Communications Commission to operate under Globalstar's HIBLEO-4 filing for a renewed 15-year term.

GSAT

Globalstar Signs Agreement With SpaceX For Falcon 9 Launch For Next Set Of Satellites, Pursuant To 2022 Satellite Procurement Agreement With MDA

Funko, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>), a leading pop culture lifestyle brand, today announced that Michael Lunsford has been appointed as the Company's Interim Chief Executive Officer, effective July 5, 2025. The appointment follows the departure of Cynthia Williams from her role as the Company's Chief Executive Officer, effective on the same date. Mr. Lunsford previously served as Funko's Interim Chief Executive Officer in 2023-2024 and continues to serve as a member of the Company's Board of Directors.
 &nbsp;

Management

FNKO

Funko Appoints Michael Lunsford As Interim CEO, Effective July 5, 2025; CEO Cynthia Williams Departs

When it comes to protecting your financial legacy, Suze Orman has one clear message: the only version of your key documents that counts is the original. In a recent "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-throwing-money-at-a-problem-does-not-always-solve-it">Women &amp; Money</a>" podcast episode, Orman and her partner, KT, addressed a listener's question about where to safely store important estate planning paperwork.&nbsp;
With natural disasters on the rise and digital copies gaining popularity, it's easy to assume a backup is enough. But according to <a href="https://www.benzinga.com/personal-finance/crowdsourcing/25/06/46157633/suze-orman-believes-the-stock-market-will-continue-climbing-without-a-shadow-of-a-doubt">Orman</a>, that's not the case.
Here's what you need to know about storing your will, trust, and other legal documents — and why originals matter most.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
<h2 class="wp-block-heading">Originals Only: Copies Won't Cut It</h2>
Listener Sherry asked whether she could give signed duplicates of her <a href="https://www.benzinga.com/personal-finance/25/05/45632293/this-119-will-trust-kit-could-save-your-family-thousands-and-its-now-20-off">estate documents</a> to family members in case the originals were destroyed. Orman didn't hesitate: "No. They are not valid."&nbsp;
In the eyes of the law, photocopies or digital scans of legal documents like a will or trust won't hold up if challenged — the original signed and notarized version is the only one that counts.
That doesn't mean copies are useless. Orman said it's still wise to share your intentions with loved ones. Even if they don't have a valid document in hand, they'll know what your wishes are and can act accordingly — especially in an emergency.
<h2 class="wp-block-heading">Best Place to Store Must-Have Documents</h2>
So, where should you keep those crucial originals? Orman recommends storing them at home in a fireproof and waterproof box. She previously sold her own line of such boxes, but even without those on the market today, similar products are widely available.&nbsp;
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
The key is to ensure the box can withstand extreme conditions — including fire, flood, or <a href="https://www.benzinga.com/news/topics/25/06/45828329/veteran-florida-weatherman-says-hes-struggling-to-forecast-hurricanes-blames-the-gutting-the-sledgehammer-attack-on-science">hurricane</a> — and is easy to grab in an emergency.
Another option is to store your documents at a trusted relative's home, especially someone who would be involved in carrying out your estate plans. If disaster strikes your area, having the documents elsewhere could be a lifesaver.&nbsp;
Just make sure this person knows exactly where the documents are and is able to take them along during an evacuation.
<h2 class="wp-block-heading">What About Safe Deposit Boxes?</h2>
Storing documents in a bank's safe deposit box may seem like a secure choice, but Orman cautions against relying on this alone. If something happens to you — or to the bank itself — your family may not be able to access what they need. Banks may be closed, damaged, or destroyed during a natural disaster. And unless your loved ones are listed on the box, they could face delays getting in, even if they know it exists.
If you do go this route, make sure more than one trusted person is named on the box and is aware of its contents and importance.
See Also: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a>
<h2 class="wp-block-heading">Replacing Lost Documents</h2>
If the worst happens and your original documents are destroyed, don't panic. Orman reassures listeners that you can reprint them — assuming they were created digitally — and simply get them notarized again. They'll then be valid once more.
If you're just starting the process, Orman recommends using musthavedocs.com, a platform she supports that offers $2,500 worth of legal documents for $99, valid in all 50 states.
Bottom line: The only valid documents are the originals. Store them in a fireproof, waterproof container — either at home or with someone you trust — and make sure your family knows where to find them.
Read Next: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Image: Shutterstock

Personal Finance

Suze Orman: Only Originals Are Valid — Here's Where to Keep Your Must-Have Docs So They Survive Anything

<ul>
<li>TSLA</li>
<li>BULL</li>
<li>GLD</li>
<li>NVDA</li>
<li>GOOGL</li>
<li>UNH</li>
<li>AAPL</li>
<li>HOOD</li>
<li>J</li>
<li>NET</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

BULL

GOOGL

HOOD

NVDA

Top 10 Trending Stocks On WallStreetBets As Of July 7, 2025 (Via Swaggy Stocks)

Goldman Sachs analyst Will Nance initiates coverage on Chime Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) with a Neutral rating and announces Price Target of $34.

CHYM

Goldman Sachs Initiates Coverage On Chime Financial with Neutral Rating, Announces Price Target of $34

Barclays analyst Alex Scott downgrades Sun Life Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SLF#TSX">SLF</a>) from Equal-Weight to Underweight and lowers the price target from C$86 to C$82.

Downgrades

TSX:SLF

Barclays Downgrades Sun Life Financial to Underweight, Lowers Price Target to C$82

Goldman Sachs analyst Lizzie Dove initiates coverage on Las Vegas Sands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) with a Neutral rating and announces Price Target of $52.

Goldman Sachs Initiates Coverage On Las Vegas Sands with Neutral Rating, Announces Price Target of $52

Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) on Monday issued preliminary second-quarter results and lowered its full-year 2025 earnings outlook, citing rising medical costs across its Medicaid, Medicare, <a href="https://www.benzinga.com/topic/medicare">and state marketplace businesses</a>.
The managed care company now expects Q2 adjusted earnings of approximately $5.50 per share—slightly below earlier forecasts—due to cost pressures that it expects will persist into the second half of the year. As a result, Molina cut its full-year 2025 adjusted EPS guidance to a range of $21.50 to $22.50, down from at <a href="https://www.benzinga.com/pressreleases/25/04/b44964747/molina-healthcare-reports-first-quarter-2025-financial-results" target="_blank" rel="noreferrer noopener">least $24.50</a> previously. The new forecast reflects a consolidated pre-tax margin just under 4%, at the low end of the company's long-term target.
Also Read: <a href="https://www.benzinga.com/news/health-care/25/07/46238442/jim-cramer-on-centenes-40-crash-fewer-aca-signups-sicker-patients-pulled-guidance-and-major-earnings-hit-trigger-selloff-this-is-horrifying" target="_blank" rel="noreferrer noopener">Jim Cramer On Centene&#8217;s 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: &#8216;This Is Horrifying&#8217;</a>
&#8220;The short-term earnings pressure we are experiencing results from what we believe to be a temporary dislocation between premium rates and medical cost trend, which has recently accelerated,&#8221; said CEO Joseph Zubretsky. &#8220;As we are still performing near our long-term target ranges, nothing, including the potential impacts of the budget bill, has changed our outlook for the long-term performance of the business.&#8221;
On Wednesday, Centene Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) withdrew its 2025 GAAP and adjusted diluted EPS guidance, stemming from its initial review of 2025 industry data from Wakely, <a target="_blank" href="https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive" rel="noreferrer noopener">an independent actuarial firm</a>.
Price Action: MOH stock is up 1.64% at $243.50 during the premarket session at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46240012/obama-warns-16-million-americans-could-lose-health-care-as-gop-pushes-trumps-big-beautiful-bill-with-deep-medicaid-cuts" target="_blank" rel="noreferrer noopener">Obama Warns 16 Million Americans Could Lose Health Care As GOP Pushes Trump&#8217;s &#8216;Big Beautiful Bill&#8217; With Deep Medicaid Cuts</a></li>
</ul>
Image: Shutterstock

Earnings

Large Cap

Guidance

Molina Healthcare Says Higher Medical Cost Trends Bite, Cuts Profit Guidance

Goldman Sachs analyst Lizzie Dove initiates coverage on MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>) with a Sell rating and announces Price Target of $34.

Goldman Sachs Initiates Coverage On MGM Resorts International with Sell Rating, Announces Price Target of $34

No gainer in today's Pre-market session. 
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">218.5700</td>
<td align="right">-2.64</td>
<td align="right">-1.20</td>
<td>10.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">86.5900</td>
<td align="right">-0.44</td>
<td align="right">-0.51</td>
<td>104.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">255.9100</td>
<td align="right">-1.05</td>
<td align="right">-0.41</td>
<td>32.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.6102</td>
<td align="right">-0.23</td>
<td align="right">-0.29</td>
<td>1.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">149.1500</td>
<td align="right">-0.27</td>
<td align="right">-0.19</td>
<td>2.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">53.0900</td>
<td align="right">-0.10</td>
<td align="right">-0.19</td>
<td>343.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">107.9100</td>
<td align="right">-0.13</td>
<td align="right">-0.13</td>
<td>1.1K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

ETFs

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For July 7, 2025

Goldman Sachs analyst Lizzie Dove initiates coverage on Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) with a Buy rating and announces Price Target of $36.

Goldman Sachs Initiates Coverage On Caesars Entertainment with Buy Rating, Announces Price Target of $36

Worksport Ltd. (NASDAQ:<a href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) ("Worksport" or the "Company"), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, announced today a transformational leap in performance—achieving a 50% increase in monthly production volume since March 2025, while delivering more than a 100% improvement in gross margins over the past five months. These milestones are underscored by readily increasing demand.
A Fundamentally Transformed Business
Following revenues of $1.5 million in 2023 and $8.5 million in 2024, Worksport is now on track to eclipse $20 million in revenue in 2025. Recently posting <a href="https://www.globenewswire.com/Tracker?data=8eG8DCUu1hXG0D2BhwN8TMUnbJ9kL0G9oI0XIIqLm7EQCL5YwEYqd3dTFUeJCTTfQrCMMrwl6zkLooNK9JKdXs6AFwcYVVPwqWfZiqlGCLMpOT9dG3-KWHR5K8iJJyPxTYJ6CAFwoGNYgeSfiSpHUWH0MNruhET7pTVXlhYcjg8APs_K0WdUaJkNjYbgSvD8nUKO1QuaYi0nE7PuUVEYJvacdsclYpjeQjksGc-kJqC2wXYmxhZhOUMKj3pLC7HeAzVMWaqWSayAS-uaGpnFSxKRiN1bMcvSrAzgiAkhBZI=">multiple consecutive months</a> of record-breaking production, growing market demand, and strong dealer adoption, the Company has rapidly evolved into a high-growth, margin-rich platform. Worksport's expects it can grow its tonneau cover business to excess of $100,000,000 annually within the short term. It sees the potential for its upcoming portable nano-grid system, the <a href="https://www.globenewswire.com/Tracker?data=URspXco2E1HpJpFxjfjbKbUcSjzadF__84Q2tedQnB7ZabhciF6pas-eY7MejzZe3te3hd7aQLiRRTR2RLs0cop6HlW-OBsg8q_EjhU40OaB5t7GJvzdE1Xm5q0Ln4mluEOd1AaIJaP71TdH0KklD8mi8qcs4Bc0_XlRxbdrI7lReUDuNWol_-Vr0pfXRkPdxIbP6GO6PxNRs28Z2ySt-A==">SOLIS and COR</a> to vastly exceed that.

WKSP

Worksport Achieves 50% Production Surge And 100%+ Gross Margin Growth Since March 2025; Projects $20M Revenue In 2025

Goldman Sachs analyst Lizzie Dove initiates coverage on Wynn Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) with a Buy rating and announces Price Target of $122.

WYNN

Goldman Sachs Initiates Coverage On Wynn Resorts with Buy Rating, Announces Price Target of $122

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS.jpeg" alt="" class="wp-image-15373" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/07081659/CS-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The operator of an app allowing users to directly convert images to PDF files from their smartphones hopes to sell investors on its growing profits and strong margins 
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Intsig has filed to list in Hong Kong, boasting nearly 30% annual profit growth over the last three years and gross profit margins of around 80%</li>
<li>CamScanner, an app allowing users to create PDF files directly from images on their phones, contributes about three-quarters of the company's revenue</li>
</ul>
Many people around the world may have used CamScanner, an application that converts documents into PDF files using photos on a smartphone. But far fewer may know the app is operated by China's&nbsp;Intsig Information Co. Ltd.&nbsp;(688615.SH), whose founder and Chairman Zhen Lixin has worked in some top firms, including oil major Sinopec, where he was an electrical engineer, and Motorola, which he joined in 2000 before setting up Intsig in 2006.
Zhen's company went through various products before hitting its stride in 2010 with CamScanner, which has grown since then to contribute over 70% of its revenue. Intsig listed on Shanghai's Nasdaq-style STAR Market last year, where it's currently valued at a hefty figure of more than 20 billion yuan ($2.8 billion). Now, the company is trying to cash in on the recent frenzy by firms listed on China's domestic-focused markets in Shanghai and Shenzhen to make a second listing in Hong Kong targeting global investors.
CamScanner bills itself as the world's largest image-to-text processing product maker by user base, according to its&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2025/107479/documents/sehk25062600499.pdf">listing document</a>filed late last month. The app has ranked at the top of the free efficiency apps list in the Apple app store "at various times" since 2013, it said, citing third-party research. With over 1 billion users across 200 countries and support in 52 languages, it says it is one of the few global apps to consistently grow at an annual rate of more than 20% for more than 15 years.
<h4 class="wp-block-heading">AI enhancements</h4>
The company has taken advantage of the recent AI boom to integrate a wide range of new features into its flagship product, with names like AI Magic Pro, AI Smart Erasure, and AI Sign. CamScanner accounted for 77% of Intsig's revenue last year, with the figure rising to 81% in the first quarter of 2025. The company's portfolio also includes other consumer-focused (2C) products like business card reader CamCard and corporate credit data app Qixinbao.
For business customers (2B), Intsig offers products like TextIn and Qixin Insight, though those account for only about 16% of its revenue. Gross profit margins for 2B products come in around 60%, notably lower than more than 80% from 2C products.
While STAR Market-listed companies are often money-losing startups, Intsig hardly fits that mold. To the contrary, the company boasts strong revenue and profits, which are both growing steadily. Its revenue grew at an average annual rate of more than 20% between 2022 and 2024, reaching 1.44 billion yuan ($201 billion) last year. Its net profit grew about 28% annually over that period to reach 400 million yuan last year. That growth continued in this year's first quarter, with its profit rising 29.4% year-on-year to 116 million yuan during the three-month period. Its gross profit margins also consistently exceeded 80% during that time.&nbsp;
<h4 class="wp-block-heading">Fierce competition</h4>
While things look good for the company right now, Intsig's listing document also outlines a number of risks it faces. It points out the rapid evolution of AI technology could erode its competitiveness if it fails to keep pace. Despite its strong position in its niche, the company holds just 2.2% of the global 2C efficiency AI product segment, showing it faces stiff competition from both domestic and international rivals. The company's possession of extensive user data also raises the risks of data breaches and privacy compliance – issues that are often more difficult for smaller, less experienced companies to handle.&nbsp;
To maintain its edge, Intsig spends heavily on R&amp;D, whose costs have risen from 279 million yuan in 2022 to 390 million yuan in 2024, equal to 27% of its revenue last year. Moreover, with about one-third of revenue coming from overseas, Intsig faces the task of managing foreign exchange risk.
Shanghai- and Shenzhen-listed companies making second IPOs in Hong Kong has become a major recent trend, but the latter are often valued lower than the former. That means that while Intsig is valued relatively high by Shanghai investors, with a current market value of about 22 billion yuan, or roughly $3 billion, it may not get such a strong valuation from global investors who are a major force in Hong Kong.&nbsp;
Among such dual listings, four out of five to debut from May onward were up from their Hong Kong IPO prices as of June 27, including electric vehicle battery giant CATL, which sold its Hong Kong shares at a 7% discount to their Shenzhen price. CATL's strong business prospects and a relatively small float for its Hong Kong listing have led the Hong Kong stock to trade at a premium to the company's Shenzhen shares. By June 27, its Hong Kong stock price had surged 24% from the IPO price to trade at a substantial 20% premium to its Shenzhen share price. But such a premium is extremely rare.
<h4 class="wp-block-heading">Mixed performance for new dual listings</h4>
Instead, the opposite is more commonly the case, with the Hong Kong shares of most dual listed companies trading at discounts of around 20% to their Shanghai- and Shenzhen-listed prices. Hengrui Pharmaceuticals and Sanhua Intelligent Controls are more typical of the group. The former is up 26% from its Hong Kong IPO price and the latter is up 8%, but both still trade at discounts to their prices on Mainland Chinese markets. Hong Kong-listed shares of leading condiment maker Haitian Flavouring have fallen 3.4% since their listing, and also trade at a 20% discount to their Shanghai-listed shares.
Intsig listed on the Shanghai STAR Market in September 2024 by selling shares for 55.18 yuan apiece. The price soared past 100 yuan on its debut and later climbed to more than 500 yuan on a wave of speculative buying. It has come down since then to currently trade at around 150 yuan, giving it a price-to-earnings (P/E) ratio that still looks relatively high at about 51 times. The company's appeal to Hong Kong investors is likely to hinge on the size of the discount it offers relative to its Shanghai share price.

Asia

IPOs

Global

Opinion

Intsig Files For Hong Kong IPO To Court Global Investors

A fresh controversy is brewing in China&#8217;s intensely competitive artificial intelligence market as Huawei Technologies&#8217; AI research arm has firmly rejected allegations of plagiarizing elements from an Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) model. This denial comes as Alibaba&#8217;s stock traded lower on Monday. 
The accusations, stemming from a paper released on GitHub on July 4 by HonestAGI, claim &#8220;extraordinary correlation&#8221; between Huawei&#8217;s recently open-sourced Pangu Pro Moe model and Alibaba&#8217;s established Qwen 2.5 14B. This development further heats up the Chinese AI landscape, which has seen a price war initiated by startups like DeepSeek earlier in 2024.
<h2 class="wp-block-heading">Huawei&#8217;s Noah&#8217;s Ark Lab Issues Strong Denial</h2>
Huawei&#8217;s Noah&#8217;s Ark Lab issued a statement Saturday to Reuters, asserting that its Pangu Pro Moe (Mixture of Experts) model was developed and trained independently.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46250853/alibabas-ai-and-cloud-moves-have-sparked-28-stock-rebound" rel="noreferrer noopener">Alibaba&#8217;s AI And Cloud Moves Have Sparked 28% Stock Rebound</a>
The denial came after HonestAGI published a paper on GitHub on Friday, claiming that Huawei&#8217;s model showed &#8220;extraordinary correlation&#8221; with Alibaba&#8217;s Qwen 2.5 14B model.
The paper argued the model appeared &#8220;upcycled&#8221; rather than trained from scratch, raising concerns about possible copyright violations, fabricated technical claims, and misrepresented training investments.
Noah&#8217;s Ark Lab rejected the claims, stating the model was not incrementally trained on others&#8217; work and featured original architectural and technical innovations. The lab added that Pangu Pro Moe is the first large model fully built on Huawei&#8217;s Ascend chips.
Huawei&#8217;s Ascend chips are a series of AI processors designed by Huawei for AI training and inference, aiming to compete with leading chipmakers like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
<h2 class="wp-block-heading">China&#8217;s Fierce AI Market And Price Wars</h2>
The allegations underscore the intense competition within China&#8217;s booming AI market. Chinese AI startup DeepSeek ignited a <a href="https://www.benzinga.com/markets/asia/25/04/45015548/baidu-goes-aggressive-chinas-in-ai-price-war-with-alibaba-deepseek">domestic price war</a> in 2024 by introducing affordable AI models, prompting tech giants like Alibaba to follow suit and further intensifying the competitive landscape.
<h2 class="wp-block-heading">Alibaba&#8217;s AI And Cloud Expansion</h2>
Alibaba stock surged 28% year-to-date, driven by increased investor confidence in China&#8217;s tech sector, strong earnings reports, and a push into artificial intelligence. 
Alibaba Cloud is <a href="https://www.benzinga.com/markets/tech/25/07/46215371/alibaba-cloud-opens-third-malaysia-data-center-plans-second-in-philippines" target="_blank" rel="noreferrer noopener">rapidly expanding overseas</a>, adding new data centers in Malaysia, South Korea, and the Philippines as part of a global push. These expansions were announced in the first half of 2025, with a third data center in Malaysia launched on July 1, 2025, and a second in the Philippines planned for October 2025.
CEO Eddie Wu has made globalization a core strategy, with plans to grow Alibaba&#8217;s cloud presence across Asia, Europe, the Middle East, and the Americas. The company will launch a global AI competency center in Singapore and expand its Qwen AI models to international data hubs by 2025. 
Backing its ambitions, Alibaba has committed $52 billion over three years to cloud and AI infrastructure, partnering with Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Nvidia.
Price Action:&nbsp;BABA shares are trading lower by&nbsp;1.37% to&nbsp;$107.40 premarket at&nbsp;last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46246152/iphone-sales-bounce-back-in-china-but-huawei-and-xiaomi-intensify-pressure" target="_blank" rel="noreferrer noopener">iPhone Sales Bounce Back In China, But Huawei And Xiaomi Intensify Pressure</a></li>
</ul>
Photo by Mamun_Sheikh via Shutterstock

Media

BABA

MSFT

Huawei-Alibaba Clash Heats Up On AI Model Plagiarism Allegations

Following a $172 million public equity raise and conversion of its balance sheet from Bitcoin to Ethereum, Bit Digital has accumulated over 100K ETH to become one of the largest corporate treasury companies in the world led under Ethereum veteran Sam Tabar
NEW YORK, July 7, 2025 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) ("Bit Digital" or the "Company"), today announced the completion of its transition to an Ethereum treasury strategy. Following the close of its recent underwritten public offering, the Company raised approximately $172 million in gross proceeds and has deployed the net capital to purchase Ethereum ("ETH"). Additionally, Bit Digital sold approximately 280 BTC and used the proceeds to purchase additional ETH.
Prior to the offering, Bit Digital held 24,434 ETH as of March 31, 2025. Following the additional ETH acquisitions funded by the net proceeds of the public offerings and the sale of its bitcoin position,&nbsp;the Company has accumulated approximately 100,603 ETH.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Comments

Tidal Trust II YieldMax BRK.B Option Income Strategy ETF

Vendite allo scoperto

Tidal Trust II YieldMax BRK.B Option Income Strategy ETF (ARCA:BRKC), Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO